http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2066059-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12ebbccf13fdf78bd50c9633c103d352
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 1992-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c99eda2d5b181bcd9b5810591cb4e534
publicationDate 1992-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2066059-A1
titleOfInvention 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
abstract ABSTRACT OF THE DISCLOSURE There is disclosed the use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds of the formula below, where X is hydrogen, loweralkyl or halogen; and R is hydrogen, loweralkyl or benzyl; for the treatment of acquired immune deficiency syndrome (AIDS).
priorityDate 1991-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID294739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410412306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23673835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409028757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10037671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407275646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1935
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID294739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834

Total number of triples: 39.